Connect with Jon Ellis and Philip Coelho from Trenchant’s team in the Innovation Zone to find out how Trenchant’s platform could shorten CAR T manufacturing time to 2.5 days. If you’re attending, reach out to us on the Phacilitate app – or through our contact page.  

Trenchant’s CEO Jon Ellis will also present the latest data on the AutoCell™ platform and its potential for cell therapy manufacturing disruption. Stay tuned!